| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |